| 前收盘价格 | 7.21 |
| 收盘价格 | 7.20 |
| 成交量 | 264,506 |
| 平均成交量 (3个月) | 304,068 |
| 市值 | 507,011,936 |
| 市盈率 (P/E TTM) | 47.31 |
| 预期市盈率 (P/E Forward) | 11.51 |
| 价格/销量 (P/S) | 1.10 |
| 股市价格/股市净资产 (P/B) | 3.67 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | -5.51% |
| 营业利益率 (TTM) | 4.01% |
| 稀释每股收益 (EPS TTM) | -0.480 |
| 季度收入增长率 (YOY) | -4.30% |
| 总债务/股东权益 (D/E MRQ) | 197.40% |
| 流动比率 (MRQ) | 1.43 |
| 营业现金流 (OCF TTM) | 25.47 M |
| 杠杆自由现金流 (LFCF TTM) | 49.52 M |
| 资产报酬率 (ROA TTM) | 3.33% |
| 股东权益报酬率 (ROE TTM) | -20.24% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Bioventus Inc. | 看涨 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 3.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.88 |
|
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 11.87% |
| 机构持股比例 | 71.55% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 16.00 (Craig-Hallum, 111.36%) | 购买 |
| 中 | 15.00 (98.15%) | |
| 低 | 14.00 (Barrington Research, 84.94%) | 购买 |
| 平均值 | 15.00 (98.15%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 8.41 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Barrington Research | 06 Mar 2026 | 14.00 (84.94%) | 购买 | 8.41 |
| 09 Feb 2026 | 13.00 (71.73%) | 购买 | 8.52 | |
| Craig-Hallum | 06 Mar 2026 | 16.00 (111.36%) | 购买 | 8.41 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 06 Jan 2026 | 公告 | Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合